UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 25, 2022
SELECTIS HEALTH, INC.
(Exact Name of Registrant as Specified in its Charter)
| Utah | | 0-15415 | | 87-0340206 |
(State or other jurisdiction of incorporation) | | Commission File Number | | (I.R.S. Employer Identification number) |
8480 E. Orchard Road, Ste. 4900, Greenwood Village, CO 80111
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (720) 680-0808
(Former name or former address, if changed since last report)
| ☐ | Written communications pursuant to Rule 425 under the Securities Act |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each Class | | Trading Symbol | | Name of each exchange on which registered |
| N/A | | N/A | | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| ITEM 5.02: | ADOPTION OF COMMITTEE CHARTERS AND APPOINTMENT OF COMMITTEE MEMBERS |
On July 25, 2022 the Board of Directors of Selectis Health, Inc, a Utah corporation (the “Company”) approved and adopted the following committee charters and policies:
Audit Committee Charter
Nominating and Governance Committee Charter
Compensation Committee Charter
Code of Conduct and Ethics Policy
Document Retention Policy
Whistleblower Policy
Copies of the above-noted charters and policies are filed herewith as Exhibits 10.1 through 10.6 respectively.
Also on July 25, 2022, the Board of Directors approved the following appointments to the Board’s standing committees:
Audit Committee:
David Furstenberg: Chairman and Audit Committee Financial Expert
Clifford Neuman
Adam Desmond
Compensation Committee
Clifford Neuman: Chairman
David Furstenberg
Adam Desmond
Nominating and Governance Committee
Adam Desmond: Chairman
David Furstenberg
Clifford Neuman
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | Selectis Health, Inc
|
| | | (Registrant) |
| | | |
| | Dated: July 29, 2022 | /s/ Lance Baller |
| | | Lance Baller, CEO |
